My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Plasma adiponectin and endogenous glucose production in humans.

    Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C, Tataranni PA.

    Diabetes Care. 2003 Dec;26(12):3315-9.PMID: 14633820 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1884-8.PMID: 12031977 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

    Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M.

    Diabetes. 2003 Feb;52(2):239-43.PMID: 12540592 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

    Hanley AJ, Connelly PW, Harris SB, Zinman B.

    Diabetes Care. 2003 Dec;26(12):3219-25.PMID: 14633805 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

    Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D.

    Diabetes Care. 2003 Aug;26(8):2383-8.PMID: 12882866 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

    Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA.

    J Clin Endocrinol Metab. 2001 May;86(5):1930-5.PMID: 11344187 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma adiponectin levels are not associated with fat oxidation in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Ravussin E, Weyer C, Tataranni PA.

    Obes Res. 2002 Oct;10(10):1016-20.PMID: 12376582 [PubMed - indexed for MEDLINE]Related articles

    9.

    High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.

    Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA.

    Diabetes. 2004 May;53(5):1279-84. Erratum in: Diabetes. 2004 Sep;53(9):2518. Volarova de Courten, B [corrected to Vozarova de Courten, B]. PMID: 15111497 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Eur J Endocrinol. 2004 May;150(5):715-8.PMID: 15132729 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

    Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS.

    Diabetes Care. 2003 Jun;26(6):1745-51.PMID: 12766104 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Plasma adiponectin concentrations in children: relationships with obesity and insulinemia.

    Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4652-6.PMID: 12364452 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.

    Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA, Baier LJ, Tataranni PA, Silver K, Bogardus C.

    Diabetes. 2003 Jun;52(6):1544-50.PMID: 12765968 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.

    Stefan N, Weyer C, Levy-Marchal C, Stumvoll M, Knowler WC, Tataranni PA, Bogardus C, Pratley RE.

    Metabolism. 2004 Jul;53(7):904-11.PMID: 15254885 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.

    Oberbach A, Tönjes A, Klöting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Blüher M.

    Eur J Endocrinol. 2006 Apr;154(4):577-85.PMID: 16556721 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.

    Weyer C, Tataranni PA, Pratley RE.

    Diabetes Care. 2000 Jun;23(6):779-85.PMID: 10840996 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.

    Osei K, Gaillard T, Kaplow J, Bullock M, Schuster D.

    Metabolism. 2004 Dec;53(12):1552-7.PMID: 15562399 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity